Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge
about
Disulfide bond structure of glycoprotein D of herpes simplex virus types 1 and 2Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalkCharacterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesLiposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria.Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness geneA synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope.Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines.Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains.Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivityEntry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virusIdentification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.Fine mapping of antigenic site II of herpes simplex virus glycoprotein DExpression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cellsThe contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein DAntigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutantsLocalization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blottingNative and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies.Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cellsInduction of conformational changes at the N-terminus of herpes simplex virus glycoprotein D upon binding to HVEM and nectin-1J-LEAPS peptide and LEAPS dendritic cell vaccines.Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro.Structural properties and reactivity of N-terminal synthetic peptides of herpes simplex virus type 1 glycoprotein D by using antipeptide antibodies and group VII monoclonal antibodies.Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
P2860
Q27486188-FB23FD29-5375-4DD8-97DC-989D76A90CDAQ27486872-D0685823-4A13-4946-97E2-74C7C7FA4282Q33248961-3726A033-C624-49AF-8074-13DFE8E47527Q33668447-CAD58E80-9DE4-4937-A0EC-830BFAD76DB5Q33997509-E8C8551E-6897-4CF1-9EFC-DFD8B4A1E7BFQ35105049-E5F7BE1B-C4FC-444E-80A2-61B50C0E0EC4Q35868054-B87262CD-3377-4901-9860-2DE2EBB56545Q36352675-E2B1B826-9FA9-42EF-BFEF-B8636067D28BQ36353364-45BF2A7E-B73A-4902-BEC3-F0BDB523E066Q36685075-AA67004E-D693-4988-AB22-3D260FEBAF8DQ36793186-29926ED0-B0C0-4C0D-B3D4-88B6A5E682C7Q36800778-0BED1069-088D-4AE6-B1BF-0502716ED9F5Q36805631-658B8D4A-9AA2-4EA7-9C41-B8578DB8BD95Q36811826-9DA147EA-A603-4F38-8021-44BC521D3644Q36825917-1FCD47C6-FFF1-440E-B72D-134F5F9E78BBQ36827278-8C987608-A5AB-4D4E-94BC-9BD378C9164EQ36827612-130A39BC-DA8B-458A-B9E7-363E3C949C91Q36868575-D1A13B6B-E0BA-4BE9-A7FD-5D0725A7A3EEQ36868606-ED303EBF-424F-4C88-AE32-F0D7A8E105C6Q36872389-360610EE-197D-43E5-8B2B-8B06B7D29869Q36883752-9E1E8E8C-002E-4AA8-8864-2F74CE5EA851Q36887606-484CA271-862D-4136-B0BF-7498706DB28CQ36906684-022E5D52-957E-4BAE-9E3D-901525F71569Q36920514-8B527E08-7DCA-4E68-914A-F7231D74F39DQ37691560-654EF4C1-AF93-49F0-8C7B-AC6597D582E0Q37927214-C6F3D57C-6A97-46F6-AA65-4BD8A4DC602DQ40114702-1C0098E3-985D-4C05-8223-E21770FA4168Q40141188-D4F10F81-30A2-40BA-AA9F-790A22BE6EB4Q55406946-7E46394C-4077-428D-97FF-81FB908400E0
P2860
Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Synthetic glycoprotein D-relat ...... herpes simplex virus challenge
@en
type
label
Synthetic glycoprotein D-relat ...... herpes simplex virus challenge
@en
prefLabel
Synthetic glycoprotein D-relat ...... herpes simplex virus challenge
@en
P2093
P2860
P1433
P1476
Synthetic glycoprotein D-relat ...... herpes simplex virus challenge
@en
P2093
A D Joseph
B Dietzschold
C J Heilman
C P Cerini
M Ponce de Leon
R J Eisenberg
P2860
P304
P407
P577
1985-12-01T00:00:00Z